Glaucoma Drug Therapy in Pregnancy: Literature Review and Teratology Information Service (TIS) Case Series.
Curr Drug Saf
; 13(1): 3-11, 2018.
Article
em En
| MEDLINE
| ID: mdl-29086700
ABSTRACT
BACKGROUND:
There are many contradictions about pregnancy and fetal/neonatal outcomes after topical use of timolol alone or timolol in combination with other antiglaucoma medications.METHODS:
Seventy-five pregnant women exposed to antiglaucoma medications were followed prospectively by phone interviews. 27 women used timolol as monotherapy, 48 women used timolol as a part of multidrug therapy. We selected a control group of 187 healthy pregnant women.RESULTS:
Topical use of timolol alone or timolol in combination with other antiglaucoma medications does not influence pregnancy or fetal/neonatal outcomes.CONCLUSION:
Beta-blocker is the first choice treatment for glaucoma in pregnancy but, when necessary, multidrug therapy should not to be excluded.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Timolol
/
Glaucoma
/
Antagonistas Adrenérgicos beta
/
Aconselhamento
/
Serviços de Informação
Tipo de estudo:
Observational_studies
/
Risk_factors_studies
Limite:
Adult
/
Female
/
Humans
/
Pregnancy
País/Região como assunto:
Europa
Idioma:
En
Revista:
Curr Drug Saf
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Itália